Hetero's new Favivir packaging for Covid-19 with 800 mg dosage cuts pill burden

▴ Hetero's new Favivir packaging for Covid-19 with 800 mg dosage cuts pill burden
The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India

Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of anti-retroviral drugs, on Friday announced the launch of first-ever "patient compliant pack" of Favivir 800/200 for the treatment of mild-to-moderate symptomatic Covid-19 patients in India.

Favivir 800/200 will be available in a patient-friendly pack containing 16 tablets of Favipiravir 800mg and 2 tablets of Favipiravir 200mg. It is priced at Rs 2,640.


The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India (DCGI). The product will be marketed and distributed by Hetero Healthcare Ltd, the company said in a statement.

The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are required to consume per day, it said.

The initial regimen of Favipiravir 200mg requires patients to consume a total of 122 tablets for the 14-day treatment course. However, with the new Favivir 800/200 pack, the pill intake number is reduced to 32 tablets, effectively cutting down the pill burden by nearly 75 per cent, leading to better treatment outcomes.


Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of Covid-19. It is an oral antiviral medication that has shown positive clinical outcomes. The product will be made available at all retail medical outlets and hospital pharmacies across the country and will be sold only on prescription.

Tags : #Favivir #Favivir800mg #Favivir800mgPricing #Hetero #FavipiravirbyHetero #Remdesivir #PatientCompliantPack #LatestPharmaNewsUpdateSep26 #LatestCovidDrugNewsSep26

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Advancing Healthcare Access: ScreenHer initiative in Pakistan close to reaching milestone of 20,000 diabetes screenings in 70 clinics February 26, 2024
FICCI Ladies Organization organized an interaction with one of the doyens of Indian IT industry Dr BVR Mohan ReddyFebruary 26, 2024
Former Secretary General of SCSC, Krishna Yedula conferred with Doctorate in HumanityFebruary 25, 2024
Project Champion School Games held February 25, 2024
Daksha 3.0, a nation level techno-test organised by Anurag University concludedFebruary 25, 2024
Mechanisation of Visakhapatnam Port is almost completeFebruary 24, 2024
Recovery Process After Contoura Surgery: Tips and Insights from an ExpertFebruary 24, 2024
Understanding Age-Related Macular Degeneration (AMD) and the Role of NutritionFebruary 24, 2024
Impact of Alcohol Consumption on Eye Health: Insights from a Senior Cataract SurgeonFebruary 23, 2024
Better health of healthcare workers in India : A Closer Look” Insights by Dr. Gopal Sharan MD & CEO of TRLS Healthcare ConsultancyFebruary 23, 2024
Chandrayaan Soft landing of India sent a strong message to the world not to take Indians light: Dr Prakash Chauhan, Director National Remote Sensing CenterFebruary 23, 2024
Dr Raj Nagarkar Leads Master Class On Robotic Surgery For Postgraduates At MASICON 2024 In NashikFebruary 23, 2024
Nanhaagyan Foundation Illuminates Pune with the Resplendent Healing Light Awards 2024February 23, 2024
Anifest India 2024: Pioneering Creativity in Pune's Animation Landscape"February 23, 2024
A Tie with a difference, promoting a cause, 17 SDGs of UNFebruary 22, 2024
Worldwide EndoMarch, Endo Run to raise mass awareness on Endometriosis!February 21, 2024
Uptick In Respiratory, and Cardiac Problems Due To Poor Air Quality In DelhiFebruary 21, 2024
Evidence shows risks associated with energy drinks in childrenFebruary 21, 2024
iHub-Data at IT-Hyderabad announces collaborative initiative with technical institutions for AI/ML training programsFebruary 20, 2024
Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic ProductionFebruary 20, 2024